[146 Pages Report] The blood group typing market is projected to reach USD 3.12 billion by 2021 from USD 1.95 billion in 2016, at a CAGR of 9.8%. The market is segmented based on product & service, technique, test type, end user, and region. Based on technique, the market is segmented into PCR-based and microarray techniques, assay-based techniques, massively parallel sequencing, and other techniques. The PCR-based and microarray techniques segment is expected to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the rising prevalence of chronic diseases and increasing R&D activities focused on understanding the molecular basis of blood and antibody-antigen interactions. Based on the end user, the market is segmented into hospitals, blood banks, clinical laboratories, and other end users. The hospitals end-user segment is expected to grow at the highest CAGR during the forecast period. This ...
Latest Healthcare Industry Updates and Trends.